Product code LGI— Clinical Toxicology

AXSYM(TM) QUINIDINE

Classification name
Fluorescence Polarization Immunoassay, Carbamazepine
Device class
Class 2
Regulation
21 CFR 862.3645
Advisory panel
Clinical Toxicology
Total cleared
3
First cleared
Most recent

Market context for product code LGI

FDA has cleared 3 devices under product code LGI between 1990 and 1994, filed by 3 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code LGI

Recent clearances under product code LGI

Data sourced from openFDA. This site is unofficial and independent of the FDA.